Livzon Pharmaceutical Group Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LVZPF research report →
About the company
Livzon Pharmaceutical Group Inc. , founded in 1985 and based in Zhuhai, China, is dedicated to the research, development, manufacturing, and distribution of a wide array of pharmaceutical products, active pharmaceutical ingredients (APIs), and related intermediates. The company's diverse range of medications includes Ilaprazole enteric-coated tablets for treating duodenal ulcers and reflux esophagitis, and Laprazole sodium for injection to manage peptic ulcer hemorrhage.
- CEO
- Daping Liu
- IPO
- 2018
- Employees
- 9,067
- HQ
- Zhuhai, CN
Price Chart
- Market Cap
- $6.06B
- P/E
- 13.69
- P/S
- 2.30
- P/B
- 1.86
- EV/EBITDA
- 7.08
- Div Yield
- 4.71%
- Gross Margin
- 65.68%
- Op Margin
- 22.67%
- Net Margin
- 16.77%
- ROE
- 13.95%
- ROIC
- 11.35%
- Revenue
- $11.60B · -1.78%
- Net Income
- $1.97B · -4.37%
- EPS
- $2.24 · 0.00%
- Op Income
- $2.56B
- FCF YoY
- 5.35%
- 52W High
- $5.22
- 52W Low
- $3.43
- 50D MA
- $5.22
- 200D MA
- $5.22
- Beta
- 0.24
- Avg Volume
- 24.908
Get TickerSpark's AI analysis on LVZPF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our LVZPF coverage
Recent articles, reports, and earnings notes.
No research on LVZPF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LVZPF report →Similar companies
Peers in the same neighborhood.